24/7 Market News Snapshot 29 Apr, 2024 – ImmunityBio Inc. (NASDAQ: IBRX)
DENVER, Colo., 29 Apr, 2024 (247marketnews.com)- Immunitybio Inc (NASDAQ:IBRX) has shown significant movement today, opening at $8.41 and currently trading at $9.703—a 32.014% increase over the previous session close of $7.350. With a current volume of 12.1M, the stock is experiencing high trading activity. The sharp increase in price suggests strong bullish momentum, potentially signaling a continuation of the upward trend. Traders and investors may view this as a buying opportunity, but should exercise caution as such rapid price movements can also indicate increased volatility. Monitoring price action and key support/resistance levels will be important to assess the stock’s future performance.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (IBRX)
- ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patients with Chemotherapy-Free, First-In-Class CD19 CAR-NK Immunotherapy
- 24/7 Market News Snapshot 13 August, 2025 – ImmunityBio, Inc. Common Stock (NASDAQ:IBRX)
- Breaking News: MoBot’s Latest Update as of 03/27/25 03:00 PM
- ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
- ImmunityBio Reports Sales Momentum & Unit Growth Since Permanent J-code Issuance (J9028) in January 2025 and Financial Results for Year End 2024